Drugs / KP-413
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00932074 | Jul 2009 → Jun 2010 | atopic eczema | Kaken Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KP-413 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00932074 ↗ |
| Route | Topical | “Study drug ointment to be applied topically to the selected treatment areas on the head/neck and torso/limbs twice a day for 4 weeks.” NCT00932074 ↗ |